Molecular Staging, Scripps Get NIDDK Grant for Genomic DNA Samples | GenomeWeb

NEW YORK, Feb. 4 - Molecular Staging of New Haven, Conn., and the Scripps Research Institute have won an award totaling up to $2.5 million from the National Institute of Diabetes and Digestive and Kidney disease (NIDDK) to produce large samples of genomic DNA for genetic disease studies, the company said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.